160 related articles for article (PubMed ID: 18723356)
21. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
[TBL] [Abstract][Full Text] [Related]
22. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
Hoover DJ; Lefkowitz-Snow S; Burgess-Henry JL; Martin WH; Armento SJ; Stock IA; McPherson RK; Genereux PE; Gibbs EM; Treadway JL
J Med Chem; 1998 Jul; 41(16):2934-8. PubMed ID: 9685232
[No Abstract] [Full Text] [Related]
23. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.
Thomson SA; Banker P; Bickett DM; Boucheron JA; Carter HL; Clancy DC; Cooper JP; Dickerson SH; Garrido DM; Nolte RT; Peat AJ; Sheckler LR; Sparks SM; Tavares FX; Wang L; Wang TY; Weiel JE
Bioorg Med Chem Lett; 2009 Feb; 19(4):1177-82. PubMed ID: 19138846
[TBL] [Abstract][Full Text] [Related]
24. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
25. Pentacyclic triterpenes. Part 2: Synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors.
Wen X; Zhang P; Liu J; Zhang L; Wu X; Ni P; Sun H
Bioorg Med Chem Lett; 2006 Feb; 16(3):722-6. PubMed ID: 16246555
[TBL] [Abstract][Full Text] [Related]
26. 5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Wright SW; Rath VL; Genereux PE; Hageman DL; Levy CB; McClure LD; McCoid SC; McPherson RK; Schelhorn TM; Wilder DE; Zavadoski WJ; Gibbs EM; Treadway JL
Bioorg Med Chem Lett; 2005 Jan; 15(2):459-65. PubMed ID: 15603973
[TBL] [Abstract][Full Text] [Related]
27. Establishment of correlation between in vitro enzyme binding potency and in vivo pharmacological activity: application to liver glycogen phosphorylase a inhibitors.
Yu LJ; Chen Y; Treadway JL; McPherson RK; McCoid SC; Gibbs EM; Hoover DJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1230-7. PubMed ID: 16537796
[TBL] [Abstract][Full Text] [Related]
28. Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.
Whittamore PR; Addie MS; Bennett SN; Birch AM; Butters M; Godfrey L; Kenny PW; Morley AD; Murray PM; Oikonomakos NG; Otterbein LR; Pannifer AD; Parker JS; Readman K; Siedlecki PS; Schofield P; Stocker A; Taylor MJ; Townsend LA; Whalley DP; Whitehouse J
Bioorg Med Chem Lett; 2006 Nov; 16(21):5567-71. PubMed ID: 16945526
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.
Chen J; Gong Y; Liu J; Hua W; Zhang L; Sun H
Chem Biodivers; 2008 Jul; 5(7):1304-12. PubMed ID: 18649317
[TBL] [Abstract][Full Text] [Related]
30. Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.
Zhang L; Li H; Zhu Q; Liu J; Chen L; Leng Y; Jiang H; Liu H
Bioorg Med Chem; 2009 Oct; 17(20):7301-12. PubMed ID: 19758809
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
Cheng K; Liu J; Sun H; Xie J
Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents.
You H; Youn HS; Im I; Bae MH; Lee SK; Ko H; Eom SH; Kim YC
Eur J Med Chem; 2011 Apr; 46(4):1153-64. PubMed ID: 21330015
[TBL] [Abstract][Full Text] [Related]
33. Modeling aided design of potent glycogen phosphorylase inhibitors.
Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
[TBL] [Abstract][Full Text] [Related]
34. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
[TBL] [Abstract][Full Text] [Related]
35. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase.
Zhang L; Chen X; Liu J; Zhu Q; Leng Y; Luo X; Jiang H; Liu H
Eur J Med Chem; 2012 Dec; 58():624-39. PubMed ID: 23178962
[TBL] [Abstract][Full Text] [Related]
38. The architecture of hydrogen and sulfur σ-hole interactions explain differences in the inhibitory potency of C-β-d-glucopyranosyl thiazoles, imidazoles and an N-β-d glucopyranosyl tetrazole for human liver glycogen phosphorylase and offer new insights to structure-based design.
Kyriakis E; Karra AG; Papaioannou O; Solovou T; Skamnaki VT; Liggri PGV; Zographos SE; Szennyes E; Bokor É; Kun S; Psarra AG; Somsák L; Leonidas DD
Bioorg Med Chem; 2020 Jan; 28(1):115196. PubMed ID: 31767404
[TBL] [Abstract][Full Text] [Related]
39. High Consistency of Structure-Based Design and X-Ray Crystallography: Design, Synthesis, Kinetic Evaluation and Crystallographic Binding Mode Determination of Biphenyl-
Fischer T; Koulas SM; Tsagkarakou AS; Kyriakis E; Stravodimos GA; Skamnaki VT; Liggri PGV; Zographos SE; Riedl R; Leonidas DD
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987252
[TBL] [Abstract][Full Text] [Related]
40. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
